5th Induced Proximity-Based Drug Discovery Summit

The 5th Induced Proximity-Based Drug Discovery Summit addresses the advancement of induced proximity-based drug discovery, focusing on strategies to enhance target identification, expand therapeutic options, and ensure successful clinical outcomes using novel modalities and AI-driven design.

Topics

• Securing investment & partnerships to de-risk the discovery pipeline
• Bridging discovery & clinical success in induced proximity drug development
• Advancing target identification strategies to prioritize high-value targets
• Engineering assays & screening strategies to strengthen target engagement
• Leveraging AI & bioinformatics for faster, more precise drug design
• Expanding the frontier of induced proximity-based drugs

Who should Attend

• Researchers in drug discovery and development
• Pharmaceutical companies and biotech professionals
• Investors and industry partners in drug development
• AI and bioinformatics experts in healthcare
• Scientists involved in assay development and screening strategies
• Clinical researchers focusing on drug safety and selectivity